A pseudo-Riemannian manifold is said to be timelike (spacelike) Osserman if the Jordan form of the Jacobi operator Kx is independent of the particular unit timelike (spacelike) tangent vector X. The first main result is that timelike (spacelike) Osserman manifold (M, g) of signature (2, 2) with the diagonalizable Jacobi operator is either locally rank-one symmetric or flat. In the nondiagonalizable case the characteristic polynomial of Kx has to have a triple zero, which is the other main result. An important step in the proof is based on Walker's study of pseudo-Riemannian manifolds admitting parallel totally isotropic distributions. Also some interesting additional geometric properties of Osserman type manifolds are established. For the nondiagonalizable Jacobi operators some of the examples show a nature of the Osserman condition for Riemannian manifolds different from that of pseudo-Riemannian manifolds.
Let p be a point of a Lorentzian manifold M. We show that if M is spacelike Osserman at p, then M has constant sectional curvature at p ; similarly, if M is timelike Osserman at p, then M has constant sectional curvature at p. The reverse implications are immediate. The timelike case and 4-dimensional spacelike case were first studied in [3] ; we use a different approach to this case.
Abstract. We study when the Jacobi operator associated to the Weyl conformal curvature tensor has constant eigenvalues on the bundle of unit spacelike or timelike tangent vectors. This leads to questions in the conformal geometry of pseudo-Riemannian manifolds which generalize the Osserman conjecture to this setting. We also study similar questions related to the skew-symmetric curvature operator defined by the Weyl conformal curvature tensor.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.